Latest ArticlesTo evaluate the efficacy and safety of muscovite-infused blood circulation and blood stasis ointment in the treatment of knee osteoarthritis (KOA).
A total of 1 600 KOA patients treated in orthopedics and traumatology departments of 11 hospitals across the country from September 2020 to December 2022 were selected and randomly divided into experimental group (n=1 200, treated with muscovite-infused blood circulation and blood stasis ointment) and control group (n=400, treated with diclofenac diethylamine emulgel) according to a ratio of 3∶1. The course of treatment in both groups was 14 days. Western Ontario and McMaster universities arthritis index (WOMAC) score, visual analogue scale (VAS), traditional Chinese medicine (TCM) syndrome score scale and knee swelling scale score, etc., and the occurrence of adverse reactions were observed in both groups.
The total effective rate of the experimental group was higher than that of the control group (86.75% vs 76.50%, P<0.05). The scores of WOMAC, VAS, TCM syndrome score scale and knee swelling scale in both groups were significantly improved, and the improvement of TCM syndrome score scale and knee swelling scale in the experimental group were better than those in the control group (P<0.05). During the treatment period, there were no adverse reactions such as drug poisoning or liver and kidney function injury in both groups.
Muscovite-infused blood circulation and blood stasis ointment can effectively improve the clinical symptoms of KOA patients, with accurate effect and high safety.
To investigate the effect of roxallistat assisted erythropoietin (EPO) on patients with renal anemia (RA) and its effect on transferrin (TRF) and TRF saturation (TSAT) levels.
A total of 179 RA patients treated in the department of nephrology, Mingguang people's hospital from January 2021 to December 2023 were selected and divided into experimental group (n=90, EPO+roxallistat) and control group (n=89, EPO) by random number table method. Both groups were treated for 12 months. The clinical efficacy, TRF, TSAT, serum indexes of anemia [red blood cell (RBC), hemoglobin (Hb), serum ferritin (SF)] and the incidence of adverse reactions were compared between the two groups.
After treatment, the clinical effective rate of experimental group was higher than that of control group (91.11% vs 79.78%, P<0.05). The levels of TRF, TSAT, RBC, Hb and SF in both groups were higher than before (P<0.05), and the experimental group was higher than the control group (P<0.05). The incidence of adverse reactions in experimental group and control group was 6.67% and 10.11%, respectively, with no significant difference (P>0.05).
Roxallistat assisted EPO in the treatment of RA is effective, and can improve the level of TRF, TSAT and anemia.
To investigate the effect of combination therapy with baritinib in the treatment of rheumatoid arthritis (RA) and influence of internal circulation state and bone metabolism.
A total of 199 RA patients treated in our hospital from January 2021 to December 2023 were selected and divided into observation group (n=100) and control group (n=99) by random number table method. The control group was treated with eramod combined with methotrexate, and the observation group was treated with baritinib on the basis of the control group, the course of treatment was 90 days. The curative effect, peak systolic velocity (PSV), peak diastolic velocity (PDV), vascular resistance, serum osteocalcin (OC), 25-hydroxyvitamin D, β-collagen degradation product (CTX), total type Ⅰ collagen amino terminal lengthening peptide (PINP), morning stiffness time, number of joint tenderness, number of joint swelling, visual analogue scale (VAS) score and incidence of adverse reactions were compared between the two groups.
After treatment, the total effective rate of observation group was higher than that of control group (91.00% vs 79.80%, P<0.05). PSV, PDV, OC, 25-hydroxyvitamin D and PINP in both groups were higher than before, and observation group was higher than control group (P<0.05). Vascular resistance, β-CTX, morning stiffness time, number of joint tenderness, number of joint swelling and VAS score in both groups were decreased, and the observation group was lower than the control group (P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).
Combination therapy with baritinib has a good effect in the adjuvant treatment of RA, and can improve the internal circulation status and bone metabolism level of patients to a certain extent.
To investigate the risk factors of brain injury in high-risk infants in neonatal intensive care unit (NICU).
A total of 655 high-risk NICU infants admitted to the second people's hospital of Wuhu from March 2019 to March 2023 were selected as the study objects, which were divided into brain injury group (n=131) and no brain injury group (n=524) according to whether brain injury occurred. Baseline data, fetal distress in uterus (FDIU), mode of delivery, mechanical ventilation (MV), assisted fertility technologies, brain-derived neurotrophic factor (BDNF), 25 hydroxyvitamin D[25(OH)D] were monitored and recorded. Univariate analysis and logistic regression analysis were used to analyze the risk factors of brain injury in NICU high-risk infants.
Compared with no brain injury group, the number of low body mass cases, FDIU cases, MV cases, prenatal risk factors, maternal infection, BDNF and 25(OH)D levels in brain injury group were higher (P<0.05). Logistic regression analysis showed that low body weight, FDIU, MV, prenatal risk factors, maternal infection, BDNF, 25(OH)D were risk factors for brain injury in NICU high-risk infants (P<0.05).
Low body mass, FDIU, MV, prenatal risk factors, maternal infection, BDNF, 25(OH)D were risk factors for brain injury in NICU high-risk infants. On the basis of considering the above factors, targeted interventions can be taken in clinic to help reduce the risk of brain injury.
In recent years, the incidence rate of atopic dermatitis (AD) has gradually increased, especially the incidence rate of AD and the proportion of severe patients in children. AD patients have obvious clinical itching symptoms, and are prone to recurrent episodes, which seriously affects the quality of life of patients and their families. In clinical practice, accurately understanding the changes in the severity of AD patients during the diagnosis and treatment is helpful to timely adjust clinical medication and treatment plans. Therefore, it is crucial to conduct standardized assessment and long-term management of the severity of skin lesions in AD patients. Currently, there are over 60 assessment tools for the severity of AD skin lesions in clinical practice, including those based on physician evaluations and patient subjective perceptions. This article systematically sorted out the usage methods, advantages and disadvantages of commonly used assessment tools based on the latest version of the national and international expert consensus, in order to facilitate clinical staff to better choose and use these assessment tools.
Non-alcoholic fatty liver disease (NAFLD) is a growing health problem worldwide, and epithelial-mesenchymal transition (EMT) plays a central role in the fibrotic progression of NAFLD. This paper reviewed the mechanism of EMT-related action in NAFLD in recent years, including transforming growth factor-β, micro RNA and extracellular vesicles, which play an important role in regulating the interaction between liver cells and fibrosis process. It provides a direction for researchers for the development of new therapeutic strategies and the research for new biomarkers for NAFLD, especially targeted interventions targeting the EMT process and its related molecules and signaling pathways, which may provide effective means to slow down or reverse fibrosis.
Sinomenine is an alkaloid monomer extracted from Caulis Sinomenii. Sinomenine was initially known for its anti-inflammatory and immunosuppression, and is mainly used in the treatment of rheumatoid arthritis (RA) and autoimmune diseases. In recent years, sinomenine have been found that it could also play an anti-breast cancer (BC) role through a variety of mechanisms, and less adverse reactions. This article reviewed the mechanism of sinomenine in the treatment of BC, in order to in order to promote the development of more studies of sinomenine in anti-tumor aspects, and provide a theoretical basis for its use in the treatment of BC.
To evaluate the cost-utility of eculizumab versus supportive therapy in the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
From the perspective of whole Chinese society, a partitioned survival model was constructed to simulate the total cost, quality-adjusted life years (QALYs) and incremental cost-effectiveness ratio (ICER) of patients over a lifetime (40 years) with a discount rate of 5%. One-way sensitivity analysis and probabilistic sensitivity analysis were used to verify the robustness of the model.
The base-case results showed that compared with supportive therapy, patients who used eculizumab could obtaine 8.50 more QALYs and an incremental cost of 639 784 CNY, the ICER was 75 297 CNY/QALY, which was lower than the GDP per capita in 2023. The one-way sensitivity analysis showed that the annual spontaneous remission rate had the most significant impact on the final result. The probabilistic sensitivity analysis showed that the probability of cost-effective of eculizumab was 99.98% when the willingness-to-pay threshold was 3 times of GDP per capital.
From the perspective of the Chinese society, eculizumab was a cost-effective treatment regimen compared to supportive therapy in the treatment of PNH patients.
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is negative for estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2, and is significantly more aggressive and progressive than other subtypes. At present, the main treatment is surgery combined chemotherapy, but treatment efficacy of the advanced TNBC patients is poor. With the in-depth study of TNBC immune microenvironment, immunotherapy has shown potential therapeutic value. The immunotherapy of TNBC mainly includes immune checkpoint blockers, cell therapy, tumor vaccines and adjustment of tumor microenvironment. This article reviewed and summarized the current status and progress of immunotherapy, which contributed to the new understanding of TNBC immunotherapy.
Breast cancer is one of the common malignant tumors, which seriously threatens women's health. As a kind of solid tumor, breast cancer can produce hypoxic areas due to the abnormal structure and function of the microvascular system. Hypoxia is generally positively associated with a more aggressive phenotype, increased risk of metastasis, and resistance to tumor therapy. In this paper, the oxygen sensing mechanisms mediated by different types of -ketoglutarate-dependent dioxygenase in breast cancer and their clinical application prospects were summarized, in order to deepen the understanding of oxygen sensing mechanisms and functions in breast cancer.